Effect of a Herbal-Leucine mix on the IL-1β-induced cartilage degradation and inflammatory gene expression in human chondrocytes

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Akhtar, Nahid ^a   Miller, Mark J S ^b   Haqqi, Tariq M ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; BOSWELLIA EXTRACT; COLLAGEN TYPE 2; COLLAGEN TYPE 2A1; COLLAGENASE 3; GELATINASE B; GLYCOSAMINOGLYCAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LEPIDIUM MEYENII EXTRACT; LEUCINE; MATRIX METALLOPROTEINASE; NITRIC OXIDE; PLANT EXTRACT; UNCARIA TOMENTOSA EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOSYNTHESIS; BOSWELLIA; CARTILAGE CELL; CARTILAGE DEGENERATION; CELL PROTECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; EXPLANT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OSTEOARTHRITIS; PROTEIN EXPRESSION; UPREGULATION; ARTICULAR CARTILAGE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; FEMALE; GENETICS; IMMUNOLOGY; LEPIDIUM; MALE; MIDDLE AGED; UNCARIA TOMENTOSA;

BOSWELLIA; CARTILAGE, ARTICULAR; CAT'S CLAW; CELLS, CULTURED; CHONDROCYTES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-1BETA; LEPIDIUM; LEUCINE; MALE; MIDDLE AGED; OSTEOARTHRITIS; PLANT EXTRACTS;

EID: 80051781277     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-66     Document Type: Article

References (49)

1. Feldmann M. Pathogenesis of arthritis: recent research progress. Nature Immunol 2001, 2:771-773.
2. Flugge LA, Miller-Deist LA, Petillo PA. Towards a molecular understanding of arthritis. Chem Biol 1999, 6(6):R157-R166. 10.1016/S1074-5521(99)80043-X, 10375544.
3. Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci 2006, 11:529-543. 10.2741/1817, 16146751.
4. Takaishi H, Kimura T, Dalal S, Okada Y, D'Armiento J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr Pharm Biotechnol 2008, 9(1):47-54. 10.2174/138920108783497659, 18289056.
5. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U, Poole AR. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage. Arthritis Rheum 2005, 52(1):128-135. 10.1002/art.20776, 15641080.
6. Goldring SR, Goldring MB. The role of cytokines in cartilage matrix degeneration in osteoarthritis. Clin Orthop Relat Res 2004, 427:S27-36.
7. Pelletier JP, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997, 40:1012-1019. 10.1002/art.1780400604, 9182910.
8. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 1991, 147:3915-3920.
9. Fermor B, Weinberg JB, Pisetsky DS, Misukonis MA, Banes AJ, Guilak F. The effects of static and intermittent compression on nitric oxide production in articular cartilage explants. J Orthop Res 2001, 19:729-737. 10.1016/S0736-0266(00)00049-8, 11518285.
10. Pelletier JP, Jovanovic D, Fernandes JC, Manning P, Connor JR, Currie MG. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998, 41:1275-1286. 10.1002/1529-0131(199807)41:7<1275::AID-ART19>3.0.CO;2-T, 9663486.
11. van den Berg WB, van de Loo F, Joosten LA, Arntz OJ. Animal models of arthritis in NOS2-deficient mice. Osteoarthritis Cartilage 1999, 7:413-415. 10.1053/joca.1999.0228, 10419784.
12. Safayhi H, Ammon HPT. Pharmakologische Aspecte von Weihrauch und Boswellias"auren. Pharmazeutisch Zeitung 1997, 142:3277-3280.
13. Chevrier MR, Ryan AE, Lee DY, Zhongze M, Wu-Yan Z, Via CS. Boswellia carterii extract inhibits TH1 cytokines and promotes TH2 cytokines in vitro. Clin Diagn Lab Immunol 2005, 12(5):575-580. 1112084, 15879017.
14. Glaser T, Winter S, Groscurth P, Safayhi H, Sailer ER, Ammon HP, Schabet M. Boswellic acids and malignant glioma: induction of apoptosis but no modulation of drug sensitivity. British J Cancer 1999, 80:756-765.
15. Zhao W, Entschladen F, Liu H, Niggemann B, Fang Q, Zenker KS, Han R. Boswellic acid acetate induced differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. Cancer Detection Prevention 2003, 27:67-75.
16. Vecera R, Orolin J, Skottová N, Kazdová L, Oliyarnik O, Ulrichová J, Simánek V. The influence of maca (Lepidium meyenii) on antioxidant status, lipid and glucose metabolism in rat. Plant Foods Hum Nutr 2007, 62(2):59-63. 10.1007/s11130-007-0042-z, 17333395.
17. Sandoval M, Okuhama NN, Zhang X-J, Condezo LA, Lao J, Angeles FM. Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are independent of their alkaloid content. Phytomedicine 2002, 9:325-337. 10.1078/0944-7113-00117, 12120814.
18. Shin BC, Lee MS, Yang EJ, Lim HS, Ernst E. Maca (L. meyenii) for improving sexual function: a systematic review. BMC Complement Altern Med 2010, 10:44. 10.1186/1472-6882-10-44, 2928177, 20691074.
19. Miller MJ, Ahmed S, Bobrowski P, Haqqi TM. The chrondoprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta. BMC Complement Altern Med 2006, 6:13. 10.1186/1472-6882-6-13, 1456997, 16603065.
20. Mehta K, Gala J, Bhasale S, Naik S, Modak M, Thakur H, Deo N, Miller MJ. Comparison of glucosamine sulfate and a polyherbal supplement for the relief of osteoarthritis of the knee: a randomized controlled trial [ISRCTN25438351]. BMC Complement Altern Med 2007, 7:34. 10.1186/1472-6882-7-34, 2131759, 17974032.
21. Piscoya J, Rodriguez Z, Bustamante SA, Okuhama NN, Miller MJS, Sandoval M. Efficacy and safety of freeze-dried cat's claw in osteoarthritis of the knee: mechanisms of action of the species Uncaria guianensis. Inflammation Res 2001, 50:442-448.
22. Sandoval M, Chaarbonnett RM, Okuhama NN, Roberts J, Krenova Z, Trentacosti AM. Cat's claw inhibits TNFa production and scavenges free radicals: role in cytoprotection. Free Rad Biol Med 2000, 29(1):71-78. 10.1016/S0891-5849(00)00327-0, 10962207.
23. Sandoval-Chacon M, Thompson JH, Zhang X-J, Liu X, Mannick EE, Sadowska-Krowicka H. Anti-inflammatory action of cat's claw: the role of NF-kB. Aliment Pharmacol Therapy 1998, 12:1279-1289.
24. Escobar J, Frank JW, Suryawan A, Nguyen HV, Kimball SR, Jefferson LS, Davis TA. Physiological rise in plasma leucine stimulates muscle protein synthesis in neonatal pigs by enhancing translation initiation factor activation. Am J Physiol Endocrinol Metab 2005, 288:E914-E921.
25. Kimball SR, Jefferson LS. Regulation of protein synthesis by branchedchain amino acids. Curr Opin Clin Nutr Metab Care 2001, 4:39-43. 10.1097/00075197-200101000-00008, 11122558.
26. Murgas TR, Suryawan A, Gazzaneo MC, Orellana RA, Frank JW, Nguyen HV, Fiorotto ML, El-Kadi S, Davis TA. Leucine supplementation of a low-protein meal increases skeletal muscle and visceral tissue protein synthesis in neonatal pigs by stimulating mTOR-dependent translation initiation. J Nutr 2010, 140(12):2145-2152. 10.3945/jn.110.128421, 20962152.
27. Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K. The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthritis Rheum 1991, 34(5):505-514. 10.1002/art.1780340502, 2025304.
28. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986, 29(8):1039-1049. 10.1002/art.1780290816, 3741515.
29. Armstrong CG, Mow VC. Variations in the intrinsic mechanical properties of human articular cartilage with age, degeneration and water content. J Bone Joint Surg 1982, 64(A):88-94.
30. Shukla M, Gupta K, Rasheed Z, Khan KA, Haqqi TM. Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1β-induced PGE2 production in human chondrocytes in vitro. J Inflamm (Lond) 2008, 5:9-18.
31. Singh R, Ahmed S, Islam N, Goldberg VM, Haqqi TM. Epigallocatechin-3-gallate inhibits interleukin-1beta-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor kappaB activation by degradation of the inhibitor of nuclear factor kappaB. Arthritis Rheum 2002, 46(8):2079-2086. 10.1002/art.10443, 12209512.
32. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29(9):e45. 10.1093/nar/29.9.e45, 55695, 11328886.
33. Palmieri B, Lodi D, Capone S. Osteoarthritis and degenerative joint disease: local treatment options update. Acta Biomed 2010, 81(2):94-100.
34. Singh R, Akhtar N, Haqqi TM. Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis. Life Sci 2010, 86(25-26):907-918. 10.1016/j.lfs.2010.04.013, 3146294, 20462508.
35. Allen-Hall L, Arnason JT, Cano P, Lafrenie RM. Uncaria tomentosa acts as a potent TNF-alpha inhibitor through NF-kappaB. J Ethnopharmacol 2010, 127(3):685-693. 10.1016/j.jep.2009.12.004, 19995599.
36. Valerio LG, Gonzales GF. Toxicological aspects of the South American herbs cat's claw (Uncaria tomentosa) and Maca (Lepidium meyenii): a critical synopsis. Toxicol Rev 2005, 24(1):11-35. 10.2165/00139709-200524010-00002, 16042502.
37. Rosenbaum CC, O'Mathúna DP, Chavez M, Shields K. Antioxidants and antiinflammatory dietary supplements for osteoarthritis and rheumatoid arthritis. Altern Ther Health Med 2010, 16(2):32-40.
38. Chopra A, Lavin P, Patwardhan B, Chitre D. A 32-week randomized, placebo-controlled clinical evaluation of RA-11, an Ayurvedic drug, on osteoarthritis of the knees. J Clin Rheumatol 2004, 10(5):236-245. 10.1097/01.rhu.0000138087.47382.6d, 17043520.
39. Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991, 33(1-2):91-95. 10.1016/0378-8741(91)90167-C, 1943180.
40. Safayhi H, Mack T, Sabieraj J, Anazodo MI, Subramanian LR, Ammon HP. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase. J Pharmacol Exp Ther 1992, 261(3):1143-1146.
41. Gupta I, Parihar A, Malhotra P, Singh GB, Lüdtke R, Safayhi H, Ammon HP. Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 1997, 2(1):37-43.
42. Crowe MJ, Weatherson JN, Bowden BF. Effects of dietary leucine supplementation on exercise performance. Eur J Appl Physiol 2006, 97(6):664-672. 10.1007/s00421-005-0036-1, 16265600.
43. Walker TB, Smith J, Herrera M, Lebegue B, Pinchak A, Fischer J. The influence of 8 weeks of whey-protein and leucine supplementation on physical and cognitive performance. Int J Sport Nutr Exerc Metab 2010, 20(5):409-417.
44. Reddy SV, Wanchu A, Khullar M, Govindrajan S, Bambery P. Leflunomide reduces nitric oxide production in patients with active rheumatoid arthritis. Int Immunopharmacol 2005, 5(6):1085-1090. 10.1016/j.intimp.2004.11.013, 15829424.
45. Clutterbuck AL, Asplin KE, Harris P, Allaway D, Mobasheri A. Targeting matrix metalloproteinases in inflammatory conditions. Curr Drug Targets 2009, 10(12):1245-1254. 10.2174/138945009789753264, 19909233.
46. Sengupta K, Krishnaraju AV, Vishal AA, Mishra A, Trimurtulu G, Sarma KV, Raychaudhuri SK, Raychaudhuri SP. Comparative efficacy and tolerability of 5-Loxin and AflapinAgainst osteoarthritis of the knee: a double blind, randomized, placebo controlled clinical study. Int J Med Sci 2010, 7(6):366-377. 2974165, 21060724.
47. Blain EJ, Ali AY, Duance VC. Boswellia frereana (frankincense) suppresses cytokine-induced matrix metalloproteinase expression and production of pro-inflammatory molecules in articular cartilage. Phytother Res 2010, 24(6):905-912.
48. Ha KT, Lee TK, Kwak KH, Kim JK, Kim DI, Choi DY, Kim CH. Inhibitory effect of Cho-Deung-San on human aortic smooth muscle cell migration induced by TNF-alpha through inhibition of matrix metalloproteinase-2 and -9 activity. Vascul Pharmacol 2004, 41(3):83-90. 10.1016/j.vph.2004.05.003, 15380733.
49. Marcu KB, Otero M, Olivotto E, Borzi RM, Goldring MB. NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets 2010, 11(5):599-613. 10.2174/138945010791011938, 3076145, 20199390.